Navigation Links
Sihuan Pharmaceutical Secures SFDA Approval for Anaprazole Sodium Category 1.1 New Drug Clinical Studies
Date:7/17/2013

no drug-drug interactions as well as less side-effects on gastrointestinal, cardiovascular and respiratory systems than drugs currently available in the market. In addition, its single isomer regiment provides additional quality and predictability. The above advantages will provide a favourable market potential for Anaprazole Sodium. 

Gastrointestinal ulcers and gastric motility disorders are common in China and have a significant patient base. With the fast-paced living environment, accelerated urbanisation and the persistently high stress level in China, the incidence rates of such diseases have been increasing each year. The overall incidences of digestive disease afflict 10%-20% of the total population, and the recurrence rate of gastrointestinal ulcers is above 75%. According to MENET figures, the size of the market has exceeded RMB$27.0 billion as at the end of 2012. This brings promising market potential and prospects.

Dr. Che Fengsheng, Chairman and CEO of Sihuan Pharmaceutical, said, "Further to getting clinical trial approval for Benapenem and Imigliptin Hydrochloride, the Company has once again succeeded in having clinical approval for Anaprazole Sodium, another innovative drug, demonstrating the continuous enhancement of its R&D capabilities. Anaprazole Sodium will offer physicians and patients better treatment options after its launch, and will vigorously drive the development of the Company in the field of digestive system. This follows the launch of Roxatidine, an exclusive first-to-market generic drug this year. This will further consolidate the diversified product lines of the Company and drive its sustainable growth. Looking into the future, we will continue to bring our strong research and development capabilities into full play by developing more innovative drugs, so as to further inject new momentum into the Company's development. "

About Sihuan Pharmaceutical
'/>"/>

SOURCE Sihuan Pharmaceutical Holdings Group Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Sihuan Pharmaceutical Announces 2012 Annual Results
2. State Food and Drug Administration Grants Approval to Sihuan Pharmaceutical for Clinical Trial of Innovative Drug -- Pinoxacin Hydrochloride
3. Sihuan Pharmaceutical Collaborates with NeuroVive to Develop Two Innovative Cardio-cerebral Vascular Products in China
4. Sihuans First-to-market Generic Drug Roxatidine Receives New Drug Certificate and Approval for Production
5. Sihuan Pharmaceutical Announces 2012 Interim Results
6. Sihuans First-to-market Generic Drug Roxatidine Passes On-site Inspection for Drug Registration Conducted by the Chinese State Food and Drug Administration
7. Cree, Intuitive Surgical, Alexion Pharmaceuticals, Roche and Onyx Pharmaceuticals highlighted as Zacks Bull and Bear of the Day
8. Abuse-Deterrent Formulations of Purdues OxyContin and Endo Pharmaceuticals Opana ER Have Not Increased PCPs Comfort When Prescribing These Products for Chronic Pain
9. Valeant Pharmaceuticals To Announce 2013 Second Quarter Results On August 7, 2013
10. GW Pharmaceuticals to Report Q3 2013 Results and Host Conference Call on 5 August, 2013
11. RXi Pharmaceuticals Announces Positive Data in Second Phase 1 Multi-Dose Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... , July 24, 2014 LSI Medience ... an Agreement with Kineticos, a Raleigh-Durham, ... Kineticos will support LSI Medience in identifying opportunities ... to demonstrate utility in clinical trials. ... utility in diagnosis of sepsis, prognosis of septic ...
(Date:7/24/2014)...  The American Association for Homecare (AAHomecare) yesterday ... help address audit issues in the HME industry ... the information technology lead in shaping its HME ... billing and business management solutions for nearly 3,000 ... support this important initiative on behalf of all ...
(Date:7/24/2014)... 24, 2014 Decision Resources Group finds that, ... countries ( France , Germany ... Spain and the United Kingdom ... first once-daily long-acting beta2 agonist/inhaled corticosteroid (LABA/ICS) fixed-dose combination ... Relvar as a first-line LABA/ICS FDC in the treatment ...
Breaking Medicine Technology:LSI Medience Corporation and Kineticos Sign Agreement Related to the Presepsin Biomarker in Sepsis Management and Treatment 2Brightree Joins AAHomecare as Corporate Partner and IT Lead on HME Audit Key 2Surveyed EU5 Pulmonologists Expect that Relvar, the First Once-Daily LABA/ICS FDC, Will Experience Healthy Uptake in Asthma 2Surveyed EU5 Pulmonologists Expect that Relvar, the First Once-Daily LABA/ICS FDC, Will Experience Healthy Uptake in Asthma 3
... Shire plc (LSE: SHP, NASDAQ: SHPGY ... on the approval status and availability of ProAmatine® (midodrine ... orthostatic hypotension (SOH).  Shire has engaged in consistent dialogue ... the past 12 months in the hopes of either ...
... 22, 2011 PediaVision, maker of the new Spot vision ... upgrading their PediaVision screening units to the new Spot vision ... into the Lions Clubs on-going screening program. Dr. Hauser Weiler, ... the Lions Clubs in 1987.  He has dedicated himself to ...
Cached Medicine Technology:Shire Provides Update on ProAmatine® (midodrine HCl) 2Shire Provides Update on ProAmatine® (midodrine HCl) 3Shire Provides Update on ProAmatine® (midodrine HCl) 4Lions Clubs of Virginia Acquire 8 New Spot Vision Screeners 2Lions Clubs of Virginia Acquire 8 New Spot Vision Screeners 3Lions Clubs of Virginia Acquire 8 New Spot Vision Screeners 4
(Date:7/24/2014)... (PRWEB) July 24, 2014 Pools and beaches ... the water can be dangerous, especially for small children, so ... water safety. , According to the Centers for Disease Control ... are most at risk for water-related injuries and deaths. It’s ... safe around water, so Amica is offering the following tips ...
(Date:7/24/2014)... 24, 2014 This year the Walk ... Electric and Jackson National Life, will be held on Saturday, ... am, the Kids Fun Run at 7:50 am, the untimed ... 9 a.m. , “The Walk to End Alzheimer’s unites the ... in the fight against this devastating disease, “stated Linda Mitchell, ...
(Date:7/24/2014)... a medical device or surgical implant is put inside ... Northwestern University,s Guillermo Ameer, most of the time, that ... , "You will always get an inflammatory response to ... Northwestern,s McCormick School of Engineering and Applied Science and ... "A problem with commonly used plastic materials, in particular, ...
(Date:7/24/2014)... Hospital and the University of Tennessee Health Science Center ... drug shown to safely reduce the viral load and ... respiratory syncytial virus (RSV). RSV is the most common ... in the United States and worldwide. , The ... John DeVincenzo, MD. DeVincenzo,s Le Bonheur lab has been ...
(Date:7/24/2014)... In signing the Workforce Innovation and ... Atlanta BeltLine Workforce Partnership in Healthcare as one ... ( http://www.whitehouse.gov/ready-to-work ). The Administration called for ... economic strategy and profiled successful local efforts to ... Obama highlights the power of partnerships in Atlanta,” ...
Breaking Medicine News(10 mins):Health News:Keep Kids Safe in the Water with 5 Tips from Amica 2Health News:Alzheimer's Association Walk to End Alzheimer's Steps Off Saturday, September 20 in Denver 2Health News:Alzheimer's Association Walk to End Alzheimer's Steps Off Saturday, September 20 in Denver 3Health News:Antioxidant biomaterial promotes healing 2Health News:RSV research breakthrough to help infected children 2Health News:President Cites Atlanta BeltLine Workforce Partnership in Healthcare as National Model 2Health News:President Cites Atlanta BeltLine Workforce Partnership in Healthcare as National Model 3Health News:President Cites Atlanta BeltLine Workforce Partnership in Healthcare as National Model 4Health News:President Cites Atlanta BeltLine Workforce Partnership in Healthcare as National Model 5
... aiming to Modernize Medical Careers, for Junior Doctors is ... the program//; Doctors from Scotland have sought a clarification ... be given the option of choosing a convenient location. ... addressed to the Scottish Junior Doctors Committee (SJDC) asking ...
... C-section births is partly attributed to the increased prevalence of ... Hudson and Gwyneth Paltrow have all opted for the C-section ... apt to follow their example. ,'There's no doubt ... births has been ignited by the fact that in our ...
... of healthcare and food products major Dabur Group, is keen ... capitalise on its plans to set// up a marine biotechnology ... drug discovery center in Oman and using their marine resources ... set up a marine biotechnology center we are keen to ...
... Vice President, Dr Choong-Siew Yong said today that properly-funded ... to set them// on a strong start to good ... child psychiatrist, was responding to the Starting Strong II ... of 20 OECD nations Australia had the lowest spending ...
... of the next school year will probably see a promotion ... to apply for a chunk// of a $3-million-a-year Nutrition fund. ... Nutrition Fund as part of its support agreement with the ... be able to apply for support in promoting fruit for ...
... HIV/AIDS, owing to the indiscriminate use of injection drugs, ... put forward a recommendation to encourage programs that include ... view to bringing down the rates of the disease. ... in Eastern Europe, Asia, and Africa should begin to ...
Cached Medicine News:Health News:Dabur Research to set up Drug Discovery Center in Oman 2Health News:Make Preschool Available To All Kids - AMA 2Health News:Better Nutrition in Schools Boosted by $12m Fund 2
Sera available in three levels for the control of accuracy and precision for up to 31 analytes...
Human based material available in two levels for the control of accuracy and precision for upto 23 analytes....
CRP Liquid Conrtols level 3...
The GLU method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of glucose in serum, plasma, urine and cerebrospinal fluid....
Medicine Products: